NG
BSX icon

Novem Group’s Boston Scientific BSX Stock Holding History

Novem Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
8,330
-2,118
-20% -$115K 0.04% 328
2026
Q1 		$656K Buy
10,448
+1,018
+11% +$81.4K 0.08% 235
2025
Q4 		$899K Buy
9,430
+7,264
+335% +$712K 0.1% 201
2025
Q3 		$211K Sell
2,166
-38
-2% -$3.94K 0.02% 392
2025
Q2 		$237K Sell
2,204
-565
-20% -$57.2K 0.03% 353
2025
Q1 		$279K Buy
2,769
+301
+12% +$30.3K 0.04% 298
2024
Q4 		$220K Buy
+2,468
New +$217K 0.03% 332

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Novem Group's BSX Position: Q2 2026 in Review

Novem Group reduced its Boston Scientific (BSX) stake by 20% in Q2 2026, selling an estimated $115K and leaving 8,330 shares worth $356K. The position accounts for 0.04% of the portfolio, ranked #328.

Novem Group first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $899K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Novem Group held 8,330 shares of Boston Scientific worth $356K as of Q2 2026.
  • Novem Group sold 2,118 Boston Scientific shares in Q2 2026, an estimated $115K.
  • Boston Scientific made up 0.04% of Novem Group's portfolio in Q2 2026, its #328 holding.
  • Novem Group first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Boston Scientific position peaked at $899K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.